www.newtimespace.com
网页
综合
NewTimeSpace | Global IPO, ETF & Hard-Tech Financial Media
On 13 Nov 2026, AB&B BIO-TECH-B (02627.HK) said China's CDE approved the IND for its tetanus vaccine candidate on 12 November. On 13 Nov 2026, HENGRUI PHARMA (01276.HK) said it received clin…
2026-11-15
自动蜘蛛
相关度 4.9